MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis

被引:18
|
作者
Baba, Toshikazu [1 ]
Shinoda, Koji [1 ]
Watanabe, Mitsuru [1 ]
Sadashima, Shoko [2 ]
Matsuse, Dai [1 ]
Isobe, Noriko [1 ]
Yamasaki, Ryo [1 ]
Kaneko, Kimihiko [3 ,4 ]
Takahashi, Toshiyuki [3 ,5 ]
Iwaki, Toru [2 ]
Kira, Jun-ichi [1 ]
机构
[1] Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Neurol,Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neuropathol, 3-1-1 Maidashi, Fukuoka, Fukuoka, Japan
[3] Tohoku Univ, Dept Neurol, Sch Med, Sendai, Miyagi, Japan
[4] Natl Hosp Org Miyagi Hosp, Dept Neurol, Sendai, Miyagi, Japan
[5] Natl Hosp Org Yonezawa Hosp, Dept Neurol, Yonezawa, Yamagata, Japan
基金
日本学术振兴会;
关键词
Myelin oligodendrocyte glycoprotein (MOG); Vasculitis; PCNSV; MRI; Biopsy;
D O I
10.1016/j.msard.2019.01.053
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report a 60-year-old male with anti-myelin oligodendrocyte glycoprotein (MOG) antibody who developed progressive cognitive deterioration and behavioral changes, with no other focal signs, over 9 months. MRI showed numerous T2-hyperintense lesions with partial contrast enhancement in white and grey matter of cerebrum, cerebellum and spinal cord. A brain biopsy revealed perivascular inflammatory cell infiltration, disturbed vascular continuity and no demyelination, indicative of a lymphocytic pattern of primary CNS vasculitis (PCNSV). Contrast enhancement disappeared after immunotherapy; however, cognitive impairment was not improved. Neurologists should note that MOG antibody disease can present as immunotherapy-resistant progressive cognitive impairment with PCNSV-like histopathology.
引用
收藏
页码:48 / 50
页数:3
相关论文
共 50 条
  • [1] Rapidly progressive primary central nervous system vasculitis
    Salvarani, Carlo
    Brown, Robert D., Jr.
    Calamia, Kenneth T.
    Christianson, Teresa J. H.
    Huston, John, III
    Meschia, James F.
    Giannini, Caterina
    Miller, Dylan V.
    Hunder, Gene G.
    RHEUMATOLOGY, 2011, 50 (02) : 349 - 358
  • [2] Isolated central nervous system vasculitis manifesting as a pseudotumor
    Balboa, O.
    Hernandez, L.
    Garcia, A. I.
    Tejada, J.
    RADIOLOGIA, 2006, 48 (05): : 309 - 312
  • [3] Primary Central Nervous System Vasculitis: Is it a Single Disease?
    Hunder, Gene G.
    Salvarani, Carlo
    Brown, Robert D., Jr.
    ANNALS OF NEUROLOGY, 2010, 68 (05) : 573 - 574
  • [4] Central Nervous System Vasculitis Primary Angiitis of the Central Nervous System and Central Nervous System Manifestations of Systemic Vasculitis
    Amin, Moein
    Uchino, Ken
    Hajj-Ali, Rula A.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2023, 49 (03) : 603 - 616
  • [5] Primary central nervous system vasculitis
    Schuster, S.
    Magnus, T.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2015, 74 (10): : 854 - +
  • [6] PRIMARY VASCULITIS OF THE CENTRAL NERVOUS SYSTEM
    Froesehl, E.
    Gallmetzer, P.
    Baumgartner, C.
    CEREBROVASCULAR DISEASES, 2014, 37 : 382 - 382
  • [7] Primary Central Nervous System Vasculitis
    Salvarani, Carlo
    Hunder, Gene G.
    Brown, Robert D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (11): : 1028 - 1037
  • [8] PRIMARY CENTRAL NERVOUS SYSTEM VASCULITIS
    Salvarani, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 3 - 3
  • [9] Primary central nervous system vasculitis and moyamoya disease: similarities and differences
    Markus Kraemer
    Peter Berlit
    Journal of Neurology, 2010, 257 : 816 - 819
  • [10] Primary central nervous system vasculitis and moyamoya disease: similarities and differences
    Kraemer, Markus
    Berlit, Peter
    JOURNAL OF NEUROLOGY, 2010, 257 (05) : 816 - 819